高盐诱导肠道菌群紊乱调节盐敏感性血压的机制研究

doi:10.12114/j.issn.1007-9572.2022.0448

摘要/Abstract

摘要： 高血压严重危害人类健康，盐摄入过量是高血压的主要危险因素之一。盐敏感性血压（SSBP）是指高盐摄入所呈现的一种血压升高反应，是部分群体存在的一种血压对盐的个体易感性。近年来随着对肠道菌群的深入研究，研究者发现肠道菌群与血压、盐摄入量之间存在显著联系，肠道菌群在SSBP发生、发展中起着重要作用。本综述通过探讨膳食盐、肠道菌群和SSBP之间的关系，发现肠道菌群在高盐诱导的炎症和高血压中扮演着重要角色，阐明肠道菌群及其代谢产物紊乱和炎症免疫参与SSBP的可能机制，以期为临床提供一种通过调整肠道菌群稳态及与之相关的炎症免疫途径来防治SSBP的新思路。

关键词: 高血压, 胃肠道微生物组, 高盐, 肠道菌群, 盐敏感性, 机制

Abstract:

Excessive salt intake is a major risk for hypertension, an illness posing a serious threat to human health. Salt-sensitive blood pressure (SSBP) refers to a rising blood pressure response to relatively high salt intake, which is a susceptibility of blood pressure to salt in some individuals. Recent studies have found that gut microbiota is significantly associated with blood pressure and salt intake, and it plays an important role in the development of SSBP. We reviewed the advances in the association of dietary salt intake, gut microbiota and SSBP, and summarized that gut microbiota plays an important role in high-salt diet-induced intestinal inflammation and hypertension, indicating that gut microbiota and its disturbance as well as inflammation/immune responses may be possibly involved in the development of SSBP. This review will provide new ideas for clinical prevention and treatment of SSBP by adjusting the homeostasis of gut microbiota and related inflammatory and immune pathways.

Key words: Hypertension, Gastrointestinal microbiome, High salt, Gut microbiota, Salt sensitivity, Mechanism

肖礼其,杨莉,崔赛仙,等. 高盐诱导肠道菌群紊乱调节盐敏感性血压的机制研究[J]. 中国全科医学, 2023, 26(29): 3704-3709. DOI: 10.12114/j.issn.1007-9572.2022.0448.
XIAO Liqi,YANG Li,CUI Saixian, et al. Advances in the Association of High Salt-induced Gut Microbiota Disturbances with Salt-sensitive Blood Pressure[J]. Chinese General Practice, 2023, 26(29): 3704-3709. DOI: 10.12114/j.issn.1007-9572.2022.0448.

参考文献 54

[1]	中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2020概要[J]. 中国循环杂志，2021,36(6):521-545. DOI：10.3969/j.issn.1000-3614.2021.06.001.
[2]	MURRAY C J L, LOPEZ A D. Measuring the global burden of disease[J]. N Engl J Med，2013,369(5):448-457. DOI：10.1056/NEJMra1201534.
[3]	HE F J, LI J F, MACGREGOR G A. Effect of longer term modest salt reduction on blood pressure：Cochrane systematic review and meta-analysis of randomised trials[J]. BMJ，2013,346:f1325. DOI：10.1136/bmj.f1325.
[4]	MELL B, JALA V R, MATHEW A V, et al. Evidence for a link between gut microbiota and hypertension in the Dahl rat[J]. Physiol Genomics，2015,47(6):187-197. DOI：10.1152/physiolgenomics.00136.2014.
[5]	FERGUSON J F, ADEN L A, BARBARO N R, et al. High dietary salt-induced dendritic cell activation underlies microbial dysbiosis-associated hypertension[J]. JCI Insight，2019,5:126241. DOI：10.1172/jci.insight.126241.
[6]	VAN BEUSECUM J P, BARBARO N R, MCDOWELL Z, et al. High salt activates CD11c+ antigen-presenting cells via SGK （serum glucocorticoid kinase） 1 to promote renal inflammation and salt-sensitive hypertension[J]. Hypertension，2019,74(3):555-563. DOI：10.1161/HYPERTENSIONAHA.119.12761.
[7]	ELIJOVICH F, LAFFER C L, SAHINOZ M, et al. The gut microbiome，inflammation，and salt-sensitive hypertension[J]. Curr Hypertens Rep，2020,22(10):79. DOI：10.1007/s11906-020-01091-9.
[8]	WILCK N, MATUS M G, KEARNEY S M, et al. Salt-responsive gut commensal modulates TH17 axis and disease[J]. Nature，2017,551(7682):585-589. DOI：10.1038/nature24628.
[9]	BIER A, BRAUN T, KHASBAB R, et al. A high salt diet modulates the gut microbiota and short chain fatty acids production in a salt-sensitive hypertension rat model[J]. Nutrients，2018,10(9):E1154. DOI：10.3390/nu10091154.
[10]	WANG C, HUANG Z X, YU K Q, et al. High-salt diet has a certain impact on protein digestion and gut microbiota：a sequencing and proteome combined study[J]. Front Microbiol，2017,8:1838. DOI：10.3389/fmicb.2017.01838.
[11]	HE P J, YUN C C. Mechanisms of the regulation of the intestinal Na+/H+ exchanger NHE3[J]. J Biomed Biotechnol，2010,2010:238080. DOI：10.1155/2010/238080.
[12]	LINZ D, WIRTH K, LINZ W, et al. Antihypertensive and laxative effects by pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut[J]. Hypertension，2012,60(6):1560-1567. DOI：10.1161/HYPERTENSIONAHA.112.201590.
[13]	ENGEVIK M A, AIHARA E, MONTROSE M H, et al. Loss of NHE3 alters gut microbiota composition and influences Bacteroides thetaiotaomicron growth[J]. Am J Physiol Gastrointest Liver Physiol，2013,305(10):G697-711. DOI：10.1152/ajpgi.00184.2013.
[14]	LI X C, SOLEIMANI M, ZHU D M, et al. Proximal tubule-specific deletion of the NHE3（Na⁺/H⁺ exchanger 3） promotes the pressure-natriuresis response and lowers blood pressure in mice[J]. Hypertension，2018,72(6):1328-1336. DOI：10.1161/HYPERTENSIONAHA.118.10884.
[15]	PLUZNICK J L, PROTZKO R J, GEVORGYAN H, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation[J]. Proc Natl Acad Sci USA，2013,110(11):4410-4415. DOI：10.1073/pnas.1215927110.
[16]	MARQUES F Z, NELSON E, CHU P Y, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice[J]. Circulation，2017,135(10):964-977. DOI：10.1161/CIRCULATIONAHA.116.024545.
[17]	CHEN L, HE F J, DONG Y B, et al. Modest sodium reduction increases circulating short-chain fatty acids in untreated hypertensives：a randomized，double-blind，placebo-controlled trial[J]. Hypertension，2020,76(1):73-79. DOI：10.1161/HYPERTENSIONAHA.120.14800.
[18]	POLL B G, CHEEMA M U, PLUZNICK J L. Gut microbial metabolites and blood pressure regulation：focus on SCFAs and TMAO[J]. Physiology （Bethesda），2020,35(4):275-284. DOI：10.1152/physiol.00004.2020.
[19]	NATARAJAN N, HORI D, FLAVAHAN S, et al. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41[J]. Physiol Genomics，2016,48(11):826-834. DOI：10.1152/physiolgenomics.00089.2016.
[20]	KIMURA I, INOUE D, MAEDA T, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 （GPR41）[J]. Proc Natl Acad Sci USA，2011,108(19):8030-8035. DOI：10.1073/pnas.1016088108.
[21]	D'SOUZA W N, DOUANGPANYA J, MU S, et al. Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses[J]. PLoS One，2017,12(7):e0180190. DOI：10.1371/journal.pone.0180190.
[22]	LANIS J M, ALEXEEV E E, CURTIS V F, et al. Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia[J]. Mucosal Immunol，2017,10(5):1133-1144. DOI：10.1038/mi.2016.133.
[23]	REZQ S, ABDEL-RAHMAN A A. Central GPR109A activation mediates glutamate-dependent pressor response in conscious rats[J]. J Pharmacol Exp Ther，2016,356(2):456-465. DOI：10.1124/jpet.115.229146.
[24]	GATAREK P, KALUZNA-CZAPLINSKA J. Trimethylamine N-oxide （TMAO） in human health[J]. EXCLI J，2021,20:301-319. DOI：10.17179/excli2020-3239.
[25]	XIAO H H, LU L, POON C C, et al. The lignan-rich fraction from Sambucus Williamsii Hance ameliorates dyslipidemia and insulin resistance and modulates gut microbiota composition in ovariectomized rats[J]. Biomedecine Pharmacother，2021,137:111372. DOI：10.1016/j.biopha.2021.111372.
[26]	UFNAL M, JAZWIEC R, DADLEZ M, et al. Trimethylamine-N-oxide：a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin Ⅱ in rats[J]. Can J Cardiol，2014,30(12):1700-1705. DOI：10.1016/j.cjca.2014.09.010.
[27]	LIU J, LI T X, WU H, et al. Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulating TMAO level and CD₄⁺ T cell induced-typeⅠ inflammation[J]. Biomedecine Pharmacother，2019,112:108580. DOI：10.1016/j.biopha.2019.01.041.
[28]	BRUNT V E, CASSO A G, GIOSCIA-RYAN R A, et al. Gut microbiome-derived metabolite trimethylamine N-oxide induces aortic stiffening and increases systolic blood pressure with aging in mice and humans[J]. Hypertension，2021,78(2):499-511. DOI：10.1161/HYPERTENSIONAHA.120.16895.
[29]	JIANG S, SHUI Y J, CUI Y, et al. Gut microbiota dependent trimethylamine N-oxide aggravates angiotensinⅡ-induced hypertension[J]. Redox Biol，2021,46:102115. DOI：10.1016/j.redox.2021.102115.
[30]	BROWN J M, HAZEN S L. Microbial modulation of cardiovascular disease[J]. Nat Rev Microbiol，2018,16(3):171-181. DOI：10.1038/nrmicro.2017.149.
[31]	WINSTON J A, THERIOT C M. Diversification of host bile acids by members of the gut microbiota[J]. Gut Microbes，2020,11(2):158-171. DOI：10.1080/19490976.2019.1674124.
[32]	田盟，严俊，李汛. 胆汁酸受体在非酒精性脂肪性肝病中的作用[J]. 中国生物化学与分子生物学报，2022,38(5):587-594. DOI：10.13865/j.cnki.cjbmb.2021.07.1220.
[33]	ZHANG Y Q, WANG X P, VALES C, et al. FXR deficiency causes reduced atherosclerosis in Ldlr-/ - mice[J]. Arterioscler Thromb Vasc Biol，2006,26(10):2316-2321. DOI：10.1161/01.ATV.0000235697.35431.05.
[34]	FIORUCCI S, ZAMPELLA A, CIRINO G, et al. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation：role of gaseous mediators[J]. Am J Physiol Heart Circ Physiol，2017,312(1):H21-32. DOI：10.1152/ajpheart.00577.2016.
[35]	ISLAM K B, FUKIYA S, HAGIO M, et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats[J]. Gastroenterology，2011,141(5):1773-1781. DOI：10.1053/j.gastro.2011.07.046.
[36]	FIORUCCI S, DISTRUTTI E. Bile acid-activated receptors，intestinal microbiota，and the treatment of metabolic disorders[J]. Trends Mol Med，2015,21(11):702-714. DOI：10.1016/j.molmed.2015.09.001.
[37]	WALLACE J L, WANG R. Hydrogen sulfide-based therapeutics：exploiting a unique but ubiquitous gasotransmitter[J]. Nat Rev Drug Discov，2015,14(5):329-345. DOI：10.1038/nrd4433.
[38]	JACKSON-WEAVER O, OSMOND J M, RIDDLE M A, et al. Hydrogen sulfide dilates rat mesenteric arteries by activating endothelial large-conductance Ca²⁺-activated K⁺ channels and smooth muscle Ca²⁺ Sparks[J]. Am J Physiol Heart Circ Physiol，2013,304(11):H1446-1454. DOI：10.1152/ajpheart.00506.2012.
[39]	徐明星，刘文秀，梁雨亭，等. 硫化氢在心血管疾病中的研究进展[J]. 中国现代医学杂志，2020,30(21):34-38.
[40]	SHEN X G, CARLSTRÖM M, BORNIQUEL S, et al. Microbial regulation of host hydrogen sulfide bioavailability and metabolism[J]. Free Radic Biol Med，2013,60:195-200. DOI：10.1016/j.freeradbiomed.2013.02.024.
[41]	TOMASOVA L, DOBROWOLSKI L, JURKxOWSKA H, et al. Intracolonic hydrogen sulfide lowers blood pressure in rats[J]. Nitric Oxide，2016,60:50-58. DOI：10.1016/j.niox.2016.09.007.
[42]	LIAO Y Y, FAN Y Y, HE Q L, et al. Exogenous H₂S ameliorates high salt-induced hypertension by alleviating oxidative stress and inflammation in the paraventricular nucleus in dahl S rats[J]. Cardiovasc Toxicol，2022,22(5):477-491. DOI：10.1007/s12012-022-09729-7.
[43]	NITZ K, LACY M, ATZLER D. Amino acids and their metabolism in atherosclerosis[J]. Arterioscler Thromb Vasc Biol，2019,39(3):319-330. DOI：10.1161/ATVBAHA.118.311572.
[44]	YANO J M, YU K, DONALDSON G P, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis[J]. Cell，2015,161(2):264-276. DOI：10.1016/j.cell.2015.02.047.
[45]	VILLALÓN C M, CENTURIÓN D. Cardiovascular responses produced by 5-hydroxytriptamine：a pharmacological update on the receptors/mechanisms involved and therapeutic implications[J]. Naunyn Schmiedebergs Arch Pharmacol，2007,376(1/2):45-63. DOI：10.1007/s00210-007-0179-1.
[46]	ZHANG N. The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology[J]. J Cardiovasc Dis Res，2011,2(2):91-95. DOI：10.4103/0975-3583.83033.
[47]	HUC T, NOWINSKI A, DRAPALA A, et al. Indole and indoxyl sulfate，gut bacteria metabolites of tryptophan，change arterial blood pressure via peripheral and central mechanisms in rats[J]. Pharmacol Res，2018,130:172-179. DOI：10.1016/j.phrs.2017.12.025.
[48]	KONOPELSKI P, CHABOWSKI D, ALEKSANDROWICZ M, et al. Indole-3-propionic acid，a tryptophan-derived bacterial metabolite，increases blood pressure via cardiac and vascular mechanisms in rats[J]. Am J Physiol Regul Integr Comp Physiol，2021,321(6):R969-981. DOI：10.1152/ajpregu.00142.2021.
[49]	GESPER M, NONNAST A B H, KUMOWSKI N, et al. Gut-derived metabolite indole-3-propionic acid modulates mitochondrial function in cardiomyocytes and alters cardiac function[J]. Front Med （Lausanne），2021,8:648259. DOI：10.3389/fmed.2021.648259.
[50]	PULAKAZHI VENU V K, SAIFEDDINE M, MIHARA K, et al. The pregnane X receptor and its microbiota-derived ligand indole 3-propionic acid regulate endothelium-dependent vasodilation[J]. Am J Physiol Endocrinol Metab，2019,317(2):E350-361. DOI：10.1152/ajpendo.00572.2018.
[51]	DOU L, SALLÉE M, CERINI C, et al. The cardiovascular effect of the uremic solute indole-3 acetic acid[J]. J Am Soc Nephrol，2015,26(4):876-887. DOI：10.1681/ASN.2013121283.
[52]	KLEINEWIETFELD M, MANZEL A, TITZE J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells[J]. Nature，2013,496(7446):518-522. DOI：10.1038/nature11868.
[53]	SHAW M H, KAMADA N, KIM Y G, et al. Microbiota-induced IL-1β，but not IL-6，is critical for the development of steady-state TH17 cells in the intestine[J]. J Exp Med，2012,209(2):251-258. DOI：10.1084/jem.20111703.
[54]	IVANOV I I, FRUTOS R D E L, MANEL N, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine[J]. Cell Host Microbe，2008,4(4):337-349. DOI：10.1016/j.chom.2008.09.009.